Nav: Home

Symptom-triggered medication for neonatal opioid withdrawal yields shorter hospital stays

July 09, 2019

BOSTON - A study led by researchers at Boston Medical Center (BMC) found that symptom-triggered medication dosing for neonatal opioid withdrawal syndrome instead of infants receiving a fixed schedule of medication with a long taper reduced the length of their hospital stay. The findings, published in Hospital Pediatrics, indicate that following the novel symptom-triggered approach - developed at BMC - for administering medication could be a more effective intervention for these infants and could help reduce unnecessary medication exposure.

Neonatal Opioid Withdrawal Syndrome (NOWS) effects infants exposed to opioids in utero. With the increase in both unprescribed and prescribed opioids use in the U.S., which has not spared pregnant women, there has been a five-fold increase in the rate of NOWS over the past decade. Approximately 50 to 80 percent of opioid-exposed infants require medication to manage their symptoms of withdrawal, which usually appear two to three days after birth and can include irritability, trouble eating and sleeping, diarrhea, muscle rigidity, and difficulty soothing. Medications that are currently used to manage these symptoms include methadone, morphine, and buprenorphine. The average hospital stay for infants with NOWS who are treated with medication is 23 days and costs approximately $93,000.

During the postpartum hospitalization, all infants with NOWS are assessed based on their ability to eat, sleep and be consoled every four hours. At BMC, clinicians utilize non-pharmacologic care interventions, including parental presence at the bedside, breastfeeding, and rooming in, as first line treatment of NOWS, which studies have shown to reduce the need for medication and hospital length of stay, thus reducing costs. If an infant is having difficulties with these core functions after using the non-pharmacologic treatments, the health care team determines if medication is the appropriate next step.

In this study, for infants who required medication for NOWS, the researchers investigated two treatment approaches: between June 2016 and November 2017, the fixed schedule medication approach was used, in which methadone was dosed every eight hours with the traditional slow taper to treat NOWS. Between December 2017 and May 2018, the researchers implemented the symptom-triggered approach, which was developed by clinician researchers at BMC as a novel way to treat NOWS by focusing on treating symptoms and keeping the infants comfortable. This approach helps reduce the incidence of creating a dependence on the opioid medication, which can sometimes occur with the traditional fixed scheduled medication approach.

Infants who were treated using the symptom triggered approach had a median length of stay of 10.5 days, versus 17 days for the fixed schedule approach. The symptom triggered group had 5.6 fewer days of methadone treatment compared to the fixed-medication schedule group. In addition, the percentage of infants who were successfully treated using the symptom-triggered approach reached 100 percent by the end of the study period, and there were no adverse events resulting from this treatment approach.

"Our study showed that treating symptoms acutely with medication, and not having a fixed schedule with a long taper not only improves patient outcomes, but shortens their hospitalizations and decreases further exposure to opioid medications," said Elisha Wachman, MD, the study's corresponding author who is a neonatologist at BMC and an associate professor of pediatrics at Boston University School of Medicine. "This novel approach prioritizes the non-pharmacologic care approach for infants experiencing withdrawal symptoms and decreases the risk for unintended dependence that frequently occurs when infants are placed on prolonged methadone or morphine tapers."
-end-
The study was funded in part by the Massachusetts Health Policy Commission Neonatal Abstinence Syndrome Innovation Grant.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 514-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $116 million in sponsored research funding in fiscal year 2017. It is the 15th largest recipient of funding in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet - 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.

Boston Medical Center

Related Infants Articles:

Premature infants at greater risk of SIDS
Premature infants still have a greater risk compared to full-term babies of dying of SIDS and other sleep-related infant deaths despite recommendations from the American Academy of Pediatrics that hospital NICU's provide more safe infant sleep education to parents before they go home.
Detecting autism in infants before symptoms emerge
According to the results of a new study, a brain scan can detect functional changes in babies as young as six months of age that predicts later diagnosis with autism spectrum disorder (ASD).
Rotavirus vaccination in infants and young children
Rotaviruses (RV) are the commonest cause of diarrhea in infants and young children worldwide.
A mother's voice may help stabilize preterm infants
A recent review of published research indicates that hearing their mother's voice can benefit the health of preterm infants.
Healthy weight gain in infants
With nearly 10 percent of infants considered 'high weight for length,' University of Delaware researcher Jillian Trabulsi wants to help babies achieve a healthy weight starting with their first months of life.
Mothers and infants connect through song
Research from UM Frost School of Music provides insight into the importance of song for infants and mothers.
Infants use prefrontal cortex in learning
A group of 8-month-olds has provided evidence that, contrary to conventional wisdom, the prefrontal cortex contributes to learning during infancy.
Very premature infants: Towards better care
Born too soon, very premature infants are particularly vulnerable and need appropriate care.
Maternal vaccination again influenza associated with protection for infants
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?
Infants much less likely to get the flu if moms are vaccinated while pregnant
Babies whose moms were vaccinated against the flu while pregnant had a 70 percent reduction in confirmed flu cases compared with infants whose moms weren't immunized, study finds.

Related Infants Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...